Description

SHORT DESCRIPTION:

Montis Biosciences is develops novel immune-oncology therapeutics targeting the intersection between vascular dysfunction and immune suppression to treat solid tumours.

 

LONG DESCRIPTION:

Based in
Nation
Founded in

2020

Founding Status

$ 5 Millions - $ 10 Millions

mood_bad
  • No comments yet.
  • Add a review
      error: Content protected